Erratum: Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA (PLoS ONE (2015) 10:3 (e0120626) DOI: 10.1371/journal.pone.0107743);Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sowa, Mandy ^a   Grossmann, Kai ^a   Knütter, Ilka ^a   Hiemann, Rico ^b   Röber, Nadja ^c   Anderer, Ursula ^b   Csernok, Elena ^d   Bogdanos, Dimitrios P ^e   Borghi, Maria Orietta ^f   Meroni, Pier Luigi ^f   Schierack, Peter ^b   Reinhold, Dirk ^g   Conrad, Karsten ^c   Roggenbuck, Dirk ^a,b  

^a GA GENERIC ASSAYS GMBH   (Germany)

^b BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF MILAN   (Italy)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTICLE; AUTOIMMUNE LIVER DISEASE; AUTOMATED PATTERN RECOGNITION; AUTOMATION; BLOOD DONOR; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; INFECTION; INFLAMMATORY BOWEL DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLEXING CYTOBEAD TECHNOLOGY; NEUTROPHIL; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; ADOLESCENT; DIAGNOSTIC USE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REPRODUCIBILITY; STANDARDS; VASCULITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ROC CURVE; VASCULITIS; YOUNG ADULT;

EID: 84907266434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120626     Document Type: Erratum

References (52)

1. Bosch X, Guilabert A, Font J (2006) Antineutrophil cytoplasmic antibodies. Lancet 368: 404-418. S0140-6736(06)69114-9 [pii]; doi: 10.1016/S0140-6736(06)69114-9
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192.
3. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, et al. (2011) Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 63: 863-864. doi: 10.1002/art.30286
4. Savige J, Gillis D, Benson E, Davies D, Esnault V, et al. (1999) International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 111: 507-513.
5. Wiik A (2003) Autoantibodies in vasculitis. Arthritis Res Ther 5: 147-152. DA - 20030501.
6. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, et al. (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1: 425-429. S0140-6736(85)91147-X [pii].
7. Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, et al. (2003) Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120: 312-318. doi: 10.1309/WAEP-ADW0-K4LP-UHFN
8. Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8: 139-160. doi: 10.1146/annurev-pathol-011811-132453
9. Gou SJ, Xu PC, Chen M, Zhao MH (2013) Epitope analysis of antimyeloperoxidase antibodies in patients with ANCA-associated vasculitis. PLoS One 8: e60530. doi: 10.1371/journal.pone.0060530; PONE-D-12-38469 [pii].
10. Muller A, Voswinkel J, Gottschlich S, Csernok E (2007) Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses. Ann N Y Acad Sci 1109: 84-92. DA - 20070905.
11. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126: 866-873.
12. Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, et al. (2002) Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 29: 918-923.
13. Csernok E, Holle JU (2010) Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology? Autoimmun Highlights 1: 39-43. doi: 10.1007/s13317-010-0007-3
14. Grossmann K, Roggenbuck D, Schroder C, Conrad K, Schierack P, et al. (2011) Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay. Cytometry A 79: 118-125. doi: 10.1002/cyto.a.21009
15. Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, et al. (2012) New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clinical and Developmental Immunology 2012: 284740.
16. Damoiseaux J, Steller U, Buschtez M, Vaessen M, Rosemann A, et al. (2009) EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods 348: 67-73. S0022-1759(09)00201-4 [pii]; doi: 10.1016/j.jim.2009.07.001
17. Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, et al. (2009) Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 9: 17-22. DA - 20090911.
18. Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, et al. (2010) Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 12: R40. DA - 20100402.
19. Kivity S, Gilburd B, Agmon-Levin N, Carrasco MG, Tzafrir Y, et al. (2011) A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 31: 503-509. doi: 10.1007/s10067-011-1884-1
20. Roggenbuck D, Hiemann R, Bogdanos D, Reinhold D, Conrad K (2013) Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta 421C: 168-169. S0009-8981(13)00110-1 [pii]; doi: 10.1016/j.cca.2013.03.019
21. Roggenbuck D, Hiemann R, Schierack P, Reinhold D, Conrad K (2014) Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution. Clin Chem Lab Med 52: e9-e11. doi: 10.1515/cclm-2013-0543; /j/cclm.ahead-of-print/cclm-2013-0543/cclm-2013-0543.xml [pii].
22. Roggenbuck D, Reinhold D, Hiemann R, Anderer U, Conrad K (2011) Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - A new age for confirmatory tests in SLE diagnostics. Clin Chim Acta 412: 2011-2012. S0009-8981(11)00382-2 [pii]; doi: 10.1016/j.cca.2011.07.005
23. Jennette JC (2013) Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 17: 603-606. doi: 10.1007/s10157-013-0869-6
24. Roggenbuck D, Buettner T, Hoffmann L, Schmechta H, Reinhold D, et al. (2009) High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 1173: 41-46. DA - 20090917.
25. Holle JU, Csernok E, Fredenhagen G, Backes M, Bremer JP, et al. (2010) Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis 69: 468-469. DA - 20100128.
26. Knutter I, Hiemann R, Brumma T, Buttner T, Grossmann K, et al. (2012) Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis. Arthritis Res Ther 14: R271. ar4119 [pii]; doi: 10.1186/ar4119
27. Conrad K, Roggenbuck D, Reinhold D, Dorner T (2009) Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 9: 431-435. DA - 20091216.
28. Roggenbuck D, Egerer K, von Landenberg P, Hiemann R, Feist E, et al. (2012) Antiphospholipid antibody profiling - Time for a new technical approach. Autoimmun Rev 11: 821-826.
29. Giraldo J, Vivas NM, Vila E, Badia A (2002) Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models. Pharmacol Ther 95: 21-45. S0163725802002231 [pii].
30. Zöphel K, Wunderlich G, Kotzerke J, von Landenberg P, Roggenbuck D (2009) M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays. Clin Chim Acta 403: 266. DA - 20090427.
31. Sack U, Conrad K, Csernok E, Frank I, Hiepe F, et al. (2009) Autoantibody Detection Using Indirect Immunofluorescence on HEp-2 Cells. Ann N Y Acad Sci 1173: 166-173. doi: 10.1111
32. Conrad K, Roggenbuck D, Reinhold D, Sack U (2011) Autoantibody diagnostics in clinical practice. Autoimmun Rev 207-211. S1568-9972(11)00116-9 [pii]; doi: 10.1016/j.autrev.2011.05.014
33. Radice A, Bianchi L, Maggiore U, Vaglio A, Sinico RA (2013) Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener's). Clin Chem Lab Med 1-9. doi: 10.1515/cclm-2013-0308; /j/cclm.ahead-of-print/cclm-2013-0308/cclm-2013-0308.xml [pii].
34. Csernok E, Ahlquist D, Ullrich S, Gross WL (2002) A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 41: 1313-1317. DA - 20021107.
35. Holle JU, Herrmann K, Gross WL, Csernok E (2012) Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA - associated vasculitides. Experimental Rheumatol 1-4.
36. Damoiseaux J, Dahnrich C, Rosemann A, Probst C, Komorowski L, et al. (2009) A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 68: 228-233. DA - 20090113.
37. Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, et al. (2012) Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 51(1): 1-10.
38. Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69: 1420-1422. ard.2009.127100 [pii]; doi: 10.1136/ard.2009.127100
39. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, et al. (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73: 17-23. annrheumdis-2013-203863 [pii]; doi: 10.1136/annrheumdis-2013-203863
40. Rodiger S, Schierack P, Bohm A, Nitschke J, Berger I, et al. (2013) A Highly Versatile Microscope Imaging Technology Platform for the Multiplex Real- Time Detection of Biomolecules and Autoimmune Antibodies. Adv Biochem Eng Biotechnol 133: 35-74. doi: 10.1007/10-2011-132
41. Damoiseaux J, Mallet K, Vaessen M, Austen J, Tervaert JWC (2012) Automatic reading of anca-slides: evaluation of the aklides system. Clin Dev Immunol 2012: 762874.
42. Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, et al. (2012) A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 11: 713-716. S1568-9972(12)00002-X [pii]; doi: 10.1016/j.autrev.2011.12.010
43. Bonroy C, Verfaillie C, Smith V, Persijn L, De Witte E, et al. (2013) Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 1-9. doi: 10.1515/cclm-2013-0016; /j/cclm.ahead-of-print/cclm-2013-0016/cclm-2013-0016.xml [pii].
44. Bossuyt X, Cooreman S, De Baere H, Verschueren P, Westhovens R, et al. (2013) Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 415: 101-106. S0009-8981(12)00456-1 [pii]; doi: 10.1016/j.cca.2012.09.021
45. George S, Paulick S, Knutter I, Rober N, Hiemann R, et al. (2014) Stable Expression of Human Muscle-Specific Kinase in HEp-2 M4 Cells for Automatic Immunofluorescence Diagnostics of Myasthenia Gravis. PLoS One 9: e83924. doi: 10.1371/journal.pone.0083924; PONE-D-13-32944 [pii].
46. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A (2000) Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 57: 846-862. kid901 [pii]; doi: 10.1046/j.1523-1755.2000.057003846.x
47. Tsiveriotis K, Tsirogianni A, Pipi E, Soufleros K, Papasteriades C (2011) Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis 2011: 626495. doi: 10.4061/2011/626495
48. Ying CM, Yao DT, Ding HH, Yang CD (2014) Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review. PLoS One 9: e89777. doi: 10.1371/journal.pone.0089777; PONE-D-13-26829 [pii].
49. Arias-Loste MT, Bonilla G, Moraleja I, Mahler M, Mieses MA, et al. (2013) Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease. Clin Rev Allergy Immunol 45: 109-116. doi: 10.1007/s12016-012-8349-4
50. Van Biervliet S, Bonroy C, Vande Velde S, De Bruyne R, Van Winckel M, et al. (2013) C-ANCA/proteinase 3-positive colitis in children: a distinctive form of inflammatory bowel disease or vasculitis with colitis as initial presentation? J Pediatr Gastroenterol Nutr 57: 489-492. doi: 10.1097/MPG.0b013e31829-d4e9e
51. Conrad K, Roggenbuck D, Laass MW (2014) Diagnosis and classification of ulcerative colitis. Autoimmun Rev. S1568-9972(14)00040-8 [pii]; doi: 10.1016/j.autrev.2014.01.028
52. Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, et al. (2003) Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods 274: 27-35. S0022175902002739 [pii].